NCT05164588 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Low L, Hodson J, Morris D, Desai P, MacEwen C
Socioeconomic deprivation and serious ocular trauma in Scotland: a national prospective study. Br J Ophthalmol. 2017 Oct;101(10):1395-1398. doi: 10.1136/bjophthalmol-2016-309875. Epub 2017 Mar 8.
Matsa E, Shi J, Wheeler KK, McCarthy T, McGregor ML, Leonard JC
Trends in US Emergency Department Visits for Pediatric Acute Ocular Injury. JAMA Ophthalmol. 2018 Aug 1;136(8):895-903. doi: 10.1001/jamaophthalmol.2018.2062. Erratum in: JAMA Ophthalmol. 2018 Aug 1;136(8):959.
Mir TA, Canner JK, Zafar S, Srikumaran D, Friedman DS, Woreta FA
Characteristics of Open Globe Injuries in the United States From 2006 to 2014. JAMA Ophthalmol. 2020 Mar 1;138(3):268-275. doi: 10.1001/jamaophthalmol.2019.5823.

A Prospective Study of Traumatic Eye Injuries in the Period From January 2022 to June 2022 in Sohag University Hospitals

Clinical trial NCT05164588 - References